# Treatment Evaluation of Neuromodulation for Tinnitus - Stage A3

> **NCT05227365** · NA · COMPLETED · sponsor: **Neuromod Devices Ltd.** · enrollment: 112 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DEVICE:** Lenire

## Key facts

- **NCT ID:** NCT05227365
- **Lead sponsor:** Neuromod Devices Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-21
- **Primary completion:** 2022-09-06
- **Final completion:** 2022-10-25
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2022-12-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227365, "Treatment Evaluation of Neuromodulation for Tinnitus - Stage A3". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05227365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*